What this means
This paper proposes a theory that signals between cells across the body shape how fast aging speeds up. It is an idea, not a tested result, so it does not prove the theory is right.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- Not stated
- Kind of research
- A study
The science
- Original title
- From hyperfunction to systemic amplification: reframing the logic of late-life rejuvenation.
- Authors
- Sottas PE
- Journal
- Aging
- Published
- Oct 22, 2026
- Study type
- Study
- PMID
- 42906917 ↗
Abstract
Aging is often modeled, and interventions prioritized, as the near-linear accumulation of cell-intrinsic lesions; yet the exponential acceleration of late-life mortality under the Gompertz law points to an active, program-like component shaping the trajectory. Furthermore, systemic interventions - including therapeutic plasma exchange and extracellular-vesicle-based therapies - together with the transient embryonic rejuvenation phase, can induce rapid, broadly coordinated organism-level rejuvenation on timescales difficult to attribute to gradual repair alone. Here, we propose an integrative-first load-gain framework in which primary lesions provide the damage load, while the systemic communication architecture sets the gain: a systemic hyperfunction of intercellular signaling that converts slow cellular inputs into self-amplifying late-life acceleration. This architecture provides a mechanistic basis for both the embryonic biological-age reset and Gompertzian late-life acceleration by positioning organism-level coupling as a central gain-setting layer governing aging trajectories. It further implies regime-dependent therapeutic leverage: cell-autonomous approaches are most effective as early-life prevention and may slow progression in midlife, but durable late-life reversal requires systemic signaling reset that suppresses amplification and restores buffering capacity. By treating rejuvenation as a shift in the organism's regulatory state rather than local lesion repair, the framework positions partial reprogramming and other cell-autonomous strategies as complementary to systemic recalibration and most effective within a rejuvenated systemic milieu.
Sottas PE From hyperfunction to systemic amplification: reframing the logic of late-life rejuvenation. Aging. 2026. doi:10.18632/aging.206430. PMID: 42906917. https://pubmed.ncbi.nlm.nih.gov/42906917/
Related research
Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention.
Partial reprogramming by cyclic expression of Yamanaka factors has been proposed as a rejuvenation strategy, yet evaluating tissue-specific responses and potential risks remains challenging.
Partial reprogramming in aged mice reduced brain damage after a stroke-like event
Researchers turned on four reprogramming genes in older mice and then blocked a brain artery. Those mice had smaller brain damage and better movement than normal mice.
Plant extracts studied for effects on aging skin cells in a preprint
Researchers tested plant extract mixes on aged skin cells and skin samples in a lab. This is an early preprint, not yet checked by other scientists, so it does not show these mixes help real skin.
Gene SRSF1 slowed signs of aging in cells and in older mice
Scientists boosted one gene in aged human cells and in mice. It made the cells and mice look younger in some ways. This does not show it would work the same way in people.
See all research on Plasma exchange and young plasma →